semaglutide medscape | People return to their baseline weight and lose all cardiometabolic benefits in less than 2 years after stopping or Rat Medication:Tirzepatide (GLP-1 + GIP) Join us in Chicago

semaglutide medscape | People return to their baseline weight and lose all cardiometabolic benefits in less than 2 years after stopping or Rat Medication:Tirzepatide (GLP-1 + GIP) Join us in Chicago

Join us in Chicago this November for “The Next Chapter of GLP-1,” an exclusive session at the GLP-1 Shopper Summit! Industry expert Sally Lyons Wyatt from @wearecircana will dive into groundbreaking research

Gastrointestinal effects Nausea is the most common tirzepatide side effect, affecting 12-18% of users in clinical trials

Rat

Medication:Tirzepatide (GLP-1 + GIP)

Physicians most frequently cited GI side effects—particularly persistent nausea and vomiting—as the primary reasons for discontinuation